Biguanides

insulin ; Homo sapiens







102 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 35454163 Metformin in Differentiated Thyroid Cancer: Molecular Pathways and Its Clinical Implications. 2022 Apr 14 1
2 33690729 Changes in protein expression due to metformin treatment and hyperinsulinemia in a human endometrial cancer cell line. 2021 1
3 34646376 Metformin in cardiovascular diabetology: a focused review of its impact on endothelial function. 2021 1
4 31567175 Insulin Therapy in Type 2 Diabetes. 2020 Jan/Feb 1
5 30328521 Pathogenesis of Lipid Disorders in Insulin Resistance: a Brief Review. 2018 Oct 17 1
6 25328079 Addition of sitagliptin or metformin to insulin monotherapy improves blood glucose control via different effects on insulin and glucagon secretion in hyperglycemic Japanese patients with type 2 diabetes. 2015 1
7 26087341 Obesity, insulin resistance, and type 1 diabetes mellitus. 2015 Aug 1
8 26166607 Impact of Metformin on Male Reproduction. 2015 3
9 26316711 Association between glycemic control and antidiabetic drugs in type 2 diabetes mellitus patients with cardiovascular complications. 2015 1
10 23889512 Molecular mechanisms underlying physiological and receptor pleiotropic effects mediated by GLP-1R activation. 2014 Mar 1
11 24577463 Long-term metformin usage and cognitive function among older adults with diabetes. 2014 1
12 23631205 [Type 2 diabetes and impaired glucose tolerance]. 2013 Feb 1
13 24189526 Metformin: do we finally have an anti-aging drug? 2013 Nov 15 1
14 21765869 The role of insulin-sensitizing agents in the treatment of nonalcoholic steatohepatitis. 2011 Jul 1
15 21847455 Noninsulin pharmacological management of type 1 diabetes mellitus. 2011 Jul 1
16 22235508 Therapeutic effects of biguanide vs. statin in polycystic ovary syndrome: a randomized clinical trial. 2011 Jun 1 2
17 19564648 Metformin: safety in cardiac patients. 2010 Jan 1
18 20122053 Biguanide, but not thiazolidinedione, improved insulin resistance in Werner syndrome. 2010 Jan 1
19 20206412 [Hepatitis C and metabolic syndrome]. 2010 Aug-Sep 2
20 20446599 [Difference between biguanide and thiazolidinedione, and the significance of combination therapy of biguanide and thiazolidinedione]. 2010 May 1
21 20460925 Insulin resistance and response to antiviral therapy in chronic hepatitis C: mechanisms and management. 2010 2
22 20547605 Metformin: safety in cardiac patients. 2010 Jun 1
23 29699342 Insulin resistance/hyperinsulinemia and reproductive disorders in infertile women. 2010 Dec 1
24 18768334 Cardiovascular prevention in type 2 diabetes mellitus patients: the role of oral glucose-lowering agents. 2009 Nov-Dec 1
25 19807652 Preservation of cellular glutathione status and mitochondrial membrane potential by N-acetylcysteine and insulin sensitizers prevent carbonyl stress-induced human brain endothelial cell apoptosis. 2009 Nov 1
26 17825080 Hepatic dysfunction and insulin insensitivity in type 2 diabetes mellitus: a critical target for insulin-sensitizing agents. 2008 Sep 1
27 19073504 Insulin-lowering effects of metformin in women with early breast cancer. 2008 Dec 2
28 24692813 Effects of replacing metformin with pioglitazone on glycemic control in japanese patients with poorly controlled type 2 diabetes mellitus: A 12-week, open-label, prospective study. 2008 Aug 1
29 17563269 Metformin/rosiglitazone combination pill (Avandamet) for the treatment of patients with Type 2 diabetes. 2007 Jun 1
30 17969380 Treatment update: thiazolidinediones in combination with metformin for the treatment of type 2 diabetes. 2007 1
31 18613325 Metformin as first choice in oral diabetes treatment: the UKPDS experience. 2007 1
32 16489105 AMPK activation restores the stimulation of glucose uptake in an in vitro model of insulin-resistant cardiomyocytes via the activation of protein kinase B. 2006 Jul 3
33 16768125 [Insulin sensitizer--anti-diabetic drugs, metformin and pioglitazone that can improve insulin resistance]. 2006 Jun 2
34 16817087 Polycystic ovary syndrome and metformin in pregnancy. 2006 1
35 16901933 Metformin reduces lipolysis in primary rat adipocytes stimulated by tumor necrosis factor-alpha or isoproterenol. 2006 Aug 1
36 16914073 Metformin and pioglitazone: Effectively treating insulin resistance. 2006 1
37 17075781 Biguanides enhance glucose utilization and insulin action in peripheral tissues: an old finding from the sixties of the last century. 2006 Oct 1
38 17087301 [Management of blood glucose--target of the management and its practice]. 2006 Nov 1
39 15798962 Improvement of liver function parameters in patients with type 2 diabetes treated with thiazolidinediones. 2005 Apr 1
40 16053338 Thiazolidinediones and insulin: rationale for use and role of combination therapy in type 2 diabetes mellitus. 2005 1
41 16219007 Combination therapy using metformin or thiazolidinediones and insulin in the treatment of diabetes mellitus. 2005 Nov 1
42 16231594 The treatment of NAFLD. 2005 Sep-Oct 1
43 17877135 [Proatherogenic lipid metabolism disturbances in impaired glucose tolerance]. 2005 Feb 1
44 14760321 Association of diabetes mellitus and glycemic control strategies with clinical outcomes after acute coronary syndromes. 2004 Feb 2
45 15206158 [Total care for patients with metabolic syndrome]. 2004 Jun 1
46 15209435 Plasma cell membrane glycoprotein 1 (PC-1): a marker of insulin resistance in obesity, uremia and diabetes mellitus. 2004 1
47 15529521 Avandamet: combined metformin-rosiglitazone treatment for insulin resistance in type 2 diabetes. 2004 Sep 1
48 12785129 Insulin resistance syndrome. Description, pathogenesis, and management. 2003 May 1
49 12946541 New developments in type 2 diabetes mellitus: combination therapy with a thiazolidinedione. 2003 Jul 2
50 14502100 Beneficial effects of metformin on haemostasis and vascular function in man. 2003 Sep 1